162 related articles for article (PubMed ID: 38465009)
1. Acromegaly among a Moroccan population.
Guerboub AA; Issouani J; Joumas KJ; Er Rahali Y
Pan Afr Med J; 2023; 46():116. PubMed ID: 38465009
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
4. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
5. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
6. Assessment of long-term remission of acromegaly following surgery.
Krieger MD; Couldwell WT; Weiss MH
J Neurosurg; 2003 Apr; 98(4):719-24. PubMed ID: 12691394
[TBL] [Abstract][Full Text] [Related]
7. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
Cardinal T; Collet C; Wedemeyer M; Singer PA; Weiss M; Zada G; Carmichael JD
Front Endocrinol (Lausanne); 2021; 12():743052. PubMed ID: 34867787
[TBL] [Abstract][Full Text] [Related]
8. [Acromegaly].
Chanson P
Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of somatostatin analogue treatment in acromegaly].
Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
11. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.
Petrossians P; Tichomirowa MA; Stevenaert A; Martin D; Daly AF; Beckers A
Ann Endocrinol (Paris); 2012 Jun; 73(3):190-201. PubMed ID: 22682917
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C; Oearsakul T
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
[TBL] [Abstract][Full Text] [Related]
14. A follow-up of 130 patients with acromegaly in a single centre.
Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
[TBL] [Abstract][Full Text] [Related]
15. [Acromegaly].
Morange I; Jaquet P
Rev Prat; 1996 Jun; 46(12):1482-5. PubMed ID: 8881161
[TBL] [Abstract][Full Text] [Related]
16. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
[TBL] [Abstract][Full Text] [Related]
17. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU; Wardlaw SL; Post KD
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[TBL] [Abstract][Full Text] [Related]
18. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
[TBL] [Abstract][Full Text] [Related]
19. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
[TBL] [Abstract][Full Text] [Related]
20. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway.
Falch CM; Dupont AK; Olarescu NC; Wiedmann M; Dahlberg D; Bollerslev J; Berg-Johnsen J; Heck A
Acta Neurochir (Wien); 2023 Oct; 165(10):3003-3010. PubMed ID: 37665404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]